Lundbeckfonden BioCapital
Overview
Lundbeckfonden BioCapital is the venture capital arm of the Lundbeck Foundation. It operates as an evergreen fund that invests in life science companies, primarily those based in Denmark, to support the translation and commercialization of new scientific research. It was formed by combining the foundation's previous investment units, Lundbeckfonden Ventures and Lundbeckfonden Emerge. The fund invests across all therapeutic areas and stages of development. Lundbeckfonden Emerge, its predecessor, was the foundation's early-stage, evergreen investment unit focused on building and financing biotech companies based on Danish research.
Portfolio Companies
9
Website
lundbeckfonden.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SNIPR Biome | Aug 2025 | Series B | Lead |
| Enterome | Jun 2025 | VC Round | Co-investor |
| Kvantify | Jul 2024 | Seed | Co-investor |
| NMD Pharma | Nov 2023 | Series B Extension | Co-investor |
| Notify Therapeutics | Sep 2023 | Seed | Lead |
Key People
Kevin Dolowy Dalgaard
Senior Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.